Yarrow Bioscience prices $150M common stock offering at $26
Yarrow Bioscience priced an underwritten public offering of 5.77M shares at $26.00 per share, targeting about $150M in gross proceeds, with a 30-day option for up to 865,384 additional shares.
00 per share, with expected gross proceeds of about $150M. The company also granted underwriters a 30-day option to buy up to an additional 865,384 shares.